Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent

CONCLUSION: MRI/FMI with a low dose of ZD2-Gd-DOTA-Cy7 enables sensitive imaging of PDAC and the quantitative assessment of fibrotic changes during AG chemotherapy, which shows potential clinical applications for precise diagnosis, post-treatment monitoring, and disease management.PMID:38372766 | DOI:10.1007/s00259-024-06617-w

Source: Cancer Control - February 19, 2024 Category: Cancer & Oncology Authors: Wenjia Zhang Xiaolong Liang Xinyu Zhang Wei Tong Guangyuan Shi Haozhuo Guo Zhengyu Jin Jie Tian Yang Du Huadan Xue Source Type: research